(Beijing / Washington Comprehensive News) After the Chinese government announced 20 measures to optimize the prevention and control of the epidemic last Friday (November 11), the Chinese Embassy in multiple countries has successively adjusted and optimized the remote prevention and control measures to go to China.Do a nucleic acid test within 48 hours before boarding, and apply for a health code with nucleic acid negative proof.
According to surging news reports, the Chinese embassies of the Chinese embassies such as the United States, the United Kingdom, India, Canada, Singapore, Saudi Arabia, Malaysia, Cambodia, Serbia, Australia, Pakistan, Russia and other national embassies have all issued further adjustments and optimization of remote prevention and control measuresThe new measures are implemented from Monday (November 14).
After adjustment, all people who take a flight to China only need to do a nucleic acid test within 48 hours before boarding, and apply for a health code with nucleic acid negative proof.
Prior to this, China's epidemic prevention policy stipulates that those who go to China must conduct two nucleic acid tests within 48 hours before taking off, and the second time must be completed within 24 hours before boarding.
Foreign sources in China will be approved to vaccinate the vaccine of the resume
China announced that 20 measures to optimize the prevention and control of the epidemic last Friday, which is regarded as one of the steps of Beijing's cautious opening of the policies for gradually relaxing the prevention and control of the epidemic.
According to Bloomberg, Sierk Poettin, chief operating officer of BIONTECH, said on Monday (November 14) at a meeting in Singapore that Chinese officials are considering approval of Fu BaitaiThe crown vaccine is urgently used in China, allowing foreigners in China to vaccinate the resupply vaccine.
When the German Chancellor Soul Titz visited China on November 5, he revealed that the Chinese government will approve the inoculation of the Biontech vaccine in foreign countries in China.
If the Fubai vaccine is approved by the Chinese government, this will be the first time that the crown vaccine developed in the West will be approved for urgent use in China.
Pheeline said that the relevant discussions of the Chinese government are still in the early stage, and there is no approval estimated timetable.
Biontech has not participated in the discussion, but has submitted all the necessary data to the Chinese government.
Of the 20 new measures launched by the Chinese government, one of them proposes to accelerate the increase of vaccine and strengthen the coverage of immune vaccination. More extensive vaccination will increase the possibility of China's re -opening up.
